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Edited by Jesus AvilaAbstract The polyubiquitin-binding protein p62 has been shown
to localize in aggregates common to several types of diseases.
Here, we report that p62 forms independent ﬁbrillar aggregates
in vitro in a time- and concentration-dependent manner. FTIR
spectra and ThT ﬂuorescence assay of p62 reveals increased b-
sheet content as aggregates form compared to the native protein.
The ﬁbrillar nature of the aggregates was observed by transmis-
sion electron microscopy. Overexpression of p62 in HEK cells
results in aggregate formation that may protect cells from apop-
tosis. Altogether, these results suggest that p62 ﬁbrils may inﬂu-
ence cell viability and indicates an important role for p62 in
aggresome formation.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Sequestosome1. Introduction
Sequestosome 1/p62 is a multimeric signaling protein that
serves a wide variety of cellular functions, including: a scaﬀold
in nuclear factor jB (NF-jB) activation, nerve growth factor-
related signal transduction during neuronal cell diﬀerentiation,
and regulation of gene transcription in the nucleus (reviewed
in [1]). Through its C-terminal ubiquitin-associating (UBA)
domain, p62 binds non-covalently to lysine 63 (K63)-linked
polyubiquitinated proteins [2]. Traditionally, K63-linked
polyubiquitin chains have been viewed as modiﬁers of protein
function, including DNA repair, stress response, and activation
of the IjBa signaling complex [3]. Recently, it has been shown
that p62 binds to proteasomal subunits Rpn10/S5a and Rpt1
through its N-terminal Phox and Bem1p (PB1) domain [2].
Together, these ﬁndings suggest that p62may serve as a shuttling
factor forK63-polyubiquitinated proteins destined for degrada-
tion by the proteasome. This is a controversial observation, asAbbreviations: AD, Alzheimers disease; GST, glutathione S-transfer-
ase; FTIR, Fourier transform infrared; ThT, Thioﬂavin T; HEK,
human embryonic kidney; NF-jB, nuclear factor jB; UBA, ubiquitin
associated; PB1, Phox and Bem1p; UPS, ubiquitin–proteasome
system; LB, Lewy body; PD, Parkinsons disease; HD, Huntingtons
disease; GFP, green ﬂuorescent protein; TEM, transmission electron
microscopy
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doi:10.1016/j.febslet.2005.08.010the generally accepted mechanism for proteolysis through the
ubiquitin–proteasome system (UPS) is the attachment of lysine
48 (K48)-linked polyubiquitin chains to the substrate, followed
by the binding of the polyubiquitin chain to the proteasome in
order to localize the substrate for degradation [3–5].
The accumulation of p62 has also been associated with neu-
rodegenerative disease. The protein has been observed to local-
ize in aggregates that are seen on analysis of brains taken from
individuals with Alzheimers disease (AD) [6,7]. p62 has also
been found in Lewy bodies (LBs), a Parkinsons disease
(PD)-associated aggregate, but not in precursors to LBs [8].
The association of p62 with neurodegenerative diseased tissues
does not appear to be a coincidental result of accumulation of
the protein, and it has been suggested that p62 plays an active
role in aggregate formation by recruiting polyubiquitinated
proteins through its UBA domain [2]. In addition, p62 is trans-
criptionally upregulated when the proteasome is inhibited, sug-
gesting that aggregate formation may be a cellular reaction to
stress conditions [8].
There are several diﬀerent proteins that can aggregate when
not degraded by the cell: a-synuclein in PD, amyloid-b (Ab)
proteins in AD, and mutant huntingtin in Huntingtons disease
(HD) are principal components of aggregates linked to neuro-
degenerative diseases. All of these proteins are also capable of
forming aggregates in vitro when incubated at suﬃcient
concentrations [9–11]. In response to accumulation of neuro-
toxic aggregates, the cell actually transports aggregates along
the microtubules to the perinuclear area of the cytosol – called
the microtubule organizing center – to form large inclusions
called aggresomes [12]. Interestingly, in at least the case of
Ab-proteins, small protoﬁlaments have been shown to be more
neurotoxic than large aggregates, suggesting that the cell
attempts to protect itself by moving all of the accumulating
proteins to one place [10,12,13].
In this study, we set out to determine whether p62 expressed
and puriﬁed from a bacterial system forms independent
aggregates in vitro. In order to characterize these aggregates,
p62 was tested to determine if the protein undergoes a confor-
mational change during the process of aggregation. Finally,
human embryonic kidney (HEK) cells that overexpress GFP-
p62 were analyzed to examine the relationship between p62
aggregation and cell survival.2. Materials and methods
2.1. GST-p62 protein preparation
Escherichia coli cells expressing GST-p62 plasmid were used for the
preparation and puriﬁcation of GST-p62 as previously described [2].
Protein concentrations were determined by Bradford Assay.blished by Elsevier B.V. All rights reserved.
Fig. 1. p62 forms independent aggregates. (A) Coomassie blue stain of
p62 aggregation. Twenty-ﬁve micromolar GST-p62 was incubated for
7 days at 37 C. Aliquots were removed at time points shown, samples
resolved by SDS–PAGE and stained with Coomassie blue. (B) Twenty-
ﬁve micromolar GST-p62 was incubated as above, and proteins were
separated by SDS–PAGE and Western blotted for p62. (C) Quanti-
ﬁcation of p62 aggregation. Band intensities of Coomassie blue stain in
(A) were analyzed. GST-p62 band (j) was quantiﬁed (with back-
ground subtraction) and band intensity was analyzed relative to t = 0.
HMW protein (m) was quantiﬁed (with background subtraction), and
band intensity was analyzed relative to t = 7 days.
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For time-dependent assays, 25 lM GST-p62 was treated with
100 mM sodium acetate and 1 mM sodium azide [14]. The protein
was incubated at 37 C with constant agitation in a MT-360 microtube
mixer (TOMY Tech USA, Inc., Fremont, CA) for up to 7 days. Ali-
quots were removed for analysis after 4–6 h, and at 1, 2, 3, and 7 days.
For the concentration-dependent assays, GST-p62 was prepared as
above at 12.5, 25, or 50 lM.
2.3. SDS–PAGE gel electrophoresis for coomassie blue stain or western
blotting
Twenty-ﬁve microliter aliquots from time points described above
were treated with 25 lL sample buﬀer, boiled, and stored at 80 C.
The proteins were separated via SDS–PAGE gel electrophoresis
employing a 10% gel and stained with Coomassie blue, or transferred
from the gel to nitrocellulose for Western Blot analysis employing
mouse monoclonal anti-p62 (Transduction Labs, Lexington, KY) or
polyclonal anti-p62 (Santa Cruz, San Diego, CA or gift of M.T.
Diaz-Meco, Madrid, Spain) [2]. The blot was processed employing
enhanced chemiluminescence (Amersham Biosciences, Piscataway,
NJ).
2.4. Fourier transform infrared spectroscopy
Infrared spectra of 25 lM GST-p62 were obtained using a Nicolet
5PC FT-IR Spectrometer [9]. A small amount of protein solution
was sandwiched between KBr discs, and a measurement was recorded.
Percent transmittance of the peak at 1638 cm1 was analyzed.
2.5. Thioﬂavin T ﬂuorescence assay
Twenty microliter GST-p62 aliquots were removed at various times
and 1 mL of 10 lM Thioﬂavin T (ThT) in 50 mM Tris–HCl (pH 8.0)
was added. After mixing for 1 min, ﬂuorescence was measured at
kex = 450 nm and kem = 482 nm on a Perkin–Elmer LS55 Lumines-
cence Spectrometer [15].
2.6. Transmission electron microscopy
After incubation of 25 lM GST-p62 as above for 7 days, the p62
aggregates were collected by centrifugation at 14000 rpm in an Eppen-
dorf Microcentrifuge for 5 min. The aggregates were ﬁxed in 3% (v/v)
glutaraldehyde in Millonigs phosphate buﬀer (0.1 M, pH 7.3), further
ﬁxed in 1% osmium tetroxide (w/v), and dehydrated in an ascending
series of ethanols ending in propylene oxide. The sample was embed-
ded in Durcupan ACM plastic (Electron Microscopy Sciences, Hat-
ﬁeld, PA), sectioned and stained with uranyl acetate and lead citrate.
Sections were examined using a Philips 301 TEM (FEI Company,
Hillsboro, OR) operating at 60 kV.
2.7. HEK cell transfection and confocal analysis
HEK 293 cells were transfected with GFP-p62 using Lipofectamine
(Gibco-BRL, Grand Island, NY) and grown at 37 C [2]. Over the
course of 7 days, cells were removed and ﬁxed. The cells were then
viewed with a Bio-Rad MRC 1024 confocal microscope.
2.8. HEK cell viability assay
HEK cells were transfected with GFP-p62. After two days, cells were
stained with LIVE/DEAD Viability/Cytotoxicity Kit (Molecular
Probes, Eugene, OR) according to the manufacturers instructions.
Using confocal/ﬂuorescence microscopy, cells with or without aggre-
gates, were scored as live (green) or dead (red), respectively.Fig. 2. Concentration-dependent aggregation of p62. GST-p62 at a
concentration of 12.5 (m- - - -m), 25 (j—j), and 50 (r––r) lM was
incubated and aliquots removed as indicated. The samples were
resolved by SDS–PAGE and stained with Coomassie blue. GST-p62
bands were analyzed relative to t = 0.3. Results
3.1. Incubation of GST-p62 leads to aggregation
To determine if p62 could form aggregates in vitro, 25 lM
GST-p62 was incubated for a period of 7 days. SDS–PAGE
followed by Coomassie blue staining revealed that the GST-
p62 band, at MW  70, disappeared with time, while high
molecular weight p62 aggregates appeared (Fig. 1A). Western
Blot analyses for p62 conﬁrm that native GSTp62 disappeared
Table 1
FTIR readings at 1638 cm1
Time (days) % Transmittance
0 27.97
5 9.525
7 2.499
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(Fig. 1B). High molecular weight p62 aggregates were detected
with both monoclonal (Fig. 1B) and polyclonal p62 antibodies
(data not shown). Taken together, these data suggest that p62
forms high molecular weight aggregates in vitro (Fig. 1C). This
ﬁnding is similar to aggregation observed for a-synuclein [15].
3.2. p62 aggregation is concentration-dependent
Numerous studies have shown that increased concentrations
of neurodegenerative disease-related proteins lead to aggrega-Fig. 4. p62 forms ﬁbrils. Transmission electron microscopy of p62 aggregate
(A) 19000 mag. (B) 54000 mag.
Fig. 3. Conformational change in p62 shown by ThT ﬂuorescence.
Twenty-ﬁve micromolar GST-p62 was incubated and aliquots were
removed at time points shown. At these times, 10 lM Thioﬂavin T was
added to each aliquot. After 1 min of mixing, the ﬂuorescence of the
solution was measured, with kex = 450 nm and kem = 482 nm
(X ± S.E.M of triplicate assays conducted with two separate prepara-
tions of p62).tion in vitro and in vivo [10,16,17]. To ﬁnd out whether the
aggregation of p62 depends on concentration, 12.5, 25, and
50 lM GST-p62 were incubated for 7 days (Fig. 2). Analysis
of the GST-p62 band at each concentration showed that
12.5 lM GST-p62 did not completely aggregate by 7 days,
25 lM GST-p62 completely aggregated by day 4, and 50 lMs reveals their ﬁbrillar nature. Fibers of various lengths were observed.
Fig. 5. Aggregation of p62 in HEK cells. HEK cells transfected with
GFP-p62 were ﬁxed at time points shown post-transfection. The cells
were then viewed with a confocal microscope.
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days the aggregates from the 50 lM prep were so large that
they became insoluble and precipitated from solution.
3.3. Native p62 protein undergoes a conformational change
during aggregation
To address whether p62 aggregates exhibit a conformational
change, we performed Fourier transform infrared (FTIR)
spectroscopy. FTIR is a method for investigation of protein
secondary structure. The FTIR spectra revealed a large change
in peak intensity at 1638 cm1 over time, suggesting that
aggregated p62 is transformed into a partially folded confor-
mation with a signiﬁcant amount of b-structures compared
to the native protein (Table 1). As a separate means of exam-
ining the b-sheet content of the aggregated preparation, ThT
binding was also examined (Fig. 3). ThT is a histological dye
that ﬂuoresces when it binds to b-sheet structure. The observed
increase in ThT ﬂuorescence over time conﬁrms a proportional
increase in the b-sheet content of p62 as it aggregates. Only
multimeric ﬁbrillar forms, not multiple b-sheet domains in na-Fig. 6. p62 aggregates are associated with living cells. (A) Two days after GF
viewed with a confocal microscope. Representative live cells stained green an
or without aggregates (n = 200) were observed and counted as alive or deadtive proteins give signiﬁcant ﬂuorescence with ThT. This
change in structure is commonly observed in amyloidous pro-
tein aggregates [14,17].
3.4. p62 aggregates form ﬁbrils
Next, we set out to further examine whether the aggregates
were amorphous or ﬁbrillar. The p62 aggregate preparations
were analyzed by transmission electron microscopy (TEM)
(Fig. 4). Observation of the images revealed that the aggregates
were composed of long ﬁbrils, which is consistent with the ThT
ﬂuorescence results (Fig. 3).
3.5. Overexpression of p62 in HEK cells leads to aggregation
and aggresome formation
To determine whether p62 forms aggregates in vivo, HEK
cells were transfected with GFP-p62, and the cells were viewed
by confocal microscopy (Fig. 5). By 12 h, small punctate
aggregates began to appear. After 2–3 days, many large aggre-
gates were visible. By 6–7 days, the aggregates appear to form
large aggresomes. To examine the eﬀects of p62 aggregation onP-p62 transfection, cells were treated with viability/cytotoxicity kit, and
d dead cells are red. Green dots are GFP-p62 aggregates. (B) Cells with
from three separate experiments (X ± S.E.M).
M.G. Paine et al. / FEBS Letters 579 (2005) 5029–5034 5033cell viability, HEK cells transfected with GFP-p62 were incu-
bated for 2 days, a live/dead stain was applied to the cells,
and then the proportion of cells that were alive or dead were
scored (Fig. 6). We observed that cells with aggregates were
more likely to be alive than dead, although there were a per-
centage of the cells overexpressing p62 that were dead. By
comparison, cells lacking p62 aggregates were more likely to
be dead than alive. Therefore, the formation of p62 aggregates
may serve a protective role and inﬂuence cell viability.4. Discussion
Here, we demonstrate that p62 can spontaneously form
ﬁbrillar b-sheet aggregates with signiﬁcant b-sheet secondary
structure. GST-p62 formed time- and concentration-
dependent aggregates in vitro. At high concentrations, these
aggregates became large inclusions that precipitated from
solution. Aggregation was coupled with an increase in the
b-sheet content of the protein, and TEM analysis revealed that
p62 aggregates are similar in structure to amyloid ﬁbrils and
other AD-type aggregates [9,10]. Although the concentrations
used in the in vitro assays are non-physiological, these ﬁndings
have implications for the role of p62 in neurodegenerative
disease.
Under normal conditions, damaged, misfolded, or otherwise
potentially neurotoxic proteins are degraded by the protea-
some [3]. However, if there is a malfunction in the UPS or
some other stress that may overload the UPS, such as an
increase in reactive oxygen species, the cell may respond by
compartmentalizing damaged proteins into aggregates
[18,19]. Aggregates were originally considered to be the neuro-
toxic species in neurodegenerative disease-eﬀected cells, but it
may be that certain proteins can become neurotoxic unless
sequestered by the cell. While the cell usually degrades these
proteins via the proteasome, there might be an alternative
mechanism to sequester dysfunctional proteins to prevent
them from interacting with native and functional proteins if
the proteasome is somehow defective. The hypothesis that
aggregation is a protective mechanism continues to gain
support [2,8,20]. Shin originally proposed that p62 binds to
polyubiquitinated proteins in order to store them in a structure
called a sequestosome, and that cellular signals cause the poly-
ubiquitinated proteins to be released from the sequestosome
for proteosomal degradation [21]. We extend this ﬁnding
demonstrating that p62 recruits dysfunctional proteins
destined for degradation via its UBA domain, which leads to
sequestration of these proteins [2], and thereby protects the cell
from potential toxic eﬀects.
Interestingly, p62 has been associated with inclusions of not
only AD but intracytoplasmic hyaline bodies [22], Mallory
bodies [23], Lewy bodies [8], and expanded polyglutamine
characteristic of HD [24], all of which contain detergent
insoluble polyubiquitinated proteins. Given our earlier
ﬁndings [2], and those herein, we propose that these diverse
inclusions represent sequestration of ubiquitinated misfolded
proteins, which arise as a response mechanism to protect the
cell from death, and may thereby delay the progression of
disease. Thus, we propose that disease progression may be
accelerated in the absence of p62 due to an inability to seques-
ter proteins in aggregates. This hypothesis is currently being
tested in p62/ mice.Acknowledgements: This study was funded in part by NINDS 33661
(M.W.W.) and College of Sciences and Mathematics Undergraduate
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